Dosimetric and radiobiologic assessment of adaptive radiotherapy by using contour based dose painting method drived from multi-parametric MRI (mpMRI) in prostate cancer patients
Dosimetric and radiobiologic assessment of treatment planning procedures DP, IMRT, 3DCRT.
Design
A randomized, clinical trial with a parallel group design of 40 patients, enrolled between September 2019 and September 2020, and followed for four month.
Settings and conduct
This study is a randomized clinical trial. The study is done on the patients with advanced prostate cancer. Processing, imaging, measuring data and treatment plannings (DP, IMRT, and 3DCRT) of the patients will be made according to specific protocols in Roshana Cancer Center.
Participants/Inclusion and exclusion criteria
The inclusion criteria : Patients with localised high-risk prostate carcinoma. Exclusion criteria : contraindications to MRI such as cardiac pacemakers.
Intervention groups
intervention group:adaptive radiotherapy by using dose painting method .
control group:radiotherapy by using common method.
Dosimetric and radiobiologic assessment of adaptive radiotherapy by using contour based dose painting method drived from multi-parametric MRI (mpMRI) in prostate cancer patients
Public title
adaptive radiotherapy in prostate cancer patients
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patients with localised high-risk prostate carcinoma
Exclusion criteria:
previousprostatectomy
general contraindications for MRI (i.e. cardiac pacemaker,metal implants )
Age
No age limit
Gender
Male
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
40
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization is performed by an independent trial center. If a patient meets the inclusion criteria and has provided informed consent, the physician contacts the trial center.The most common and basic method of simple randomization is flipping a coin, with two treatment groups (control versus treatment).This randomization approach is simple and easy to implement in a clinical research.Simple randomization works well for the large clinical trails (n>100) and for small to moderate clinical trials (n<100) without covariates
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of tarbiat modares University
Street address
Tarbiat Modares University, Al-Ahmad and Chamran Cross
City
Tehran
Province
Tehran
Postal code
1411713116
Approval date
2018-09-30, 1397/07/08
Ethics committee reference number
IR.MODARES.REC.1397.163
Health conditions studied
1
Description of health condition studied
prostate cancer
ICD-10 code
N42.3
ICD-10 code description
Dysplasia of prostate
Primary outcomes
1
Description
Tumor volume
Timepoint
Before treatment and four months after radiotherapy
Method of measurement
diffusion weighted Images (DWI)
2
Description
ADC
Timepoint
Before treatment and four months after radiotherapy
Method of measurement
diffusion weighted Images (DWI)
3
Description
Prostate-specific antigen (PSA)
Timepoint
Before treatment and four months after radiotherapy
Method of measurement
blood test
Secondary outcomes
empty
Intervention groups
1
Description
Dosimetric and radiobiologic assessment by using contour based dose painting method drived from multi-parametric MRI.
Category
Treatment - Other
2
Description
Control group: intensity-modulated radiotherapy for patients with prostate cancer
Category
Treatment - Other
Recruitment centers
1
Recruitment center
Name of recruitment center
Roshana Radiation Oncology Center (Tehran, Iran)
Full name of responsible person
Bijan Hashemi
Street address
Tarbiat Modares University, Al-Ahmad and Chamran Cross